IDO1 and cancer: When the bromopyrrole group of this compound is replaced by an indole moiety, (N-(3-((1H-Benzo[d]imidazol-1-yl) methyl) benzyl)-1H-indole-2-carboxamide) inhibits IDO1 in various cancer cell lines at low nanomolar levels and is more selective for IDO1.